Hot Pursuit     26-Jun-23
Ajanta Pharma gains after Dahej facility clears USFDA inspection
Ajanta Pharma rose 1.66% to Rs 1,485 after US Food and Drug Adminstration (USFDA) issued zero observations for the company's Dahej Facility.
The USFDA inspected the facility from 19 June 2023 to 23 June 2023. At the end of inspection, no form 483 was issued to the company's facility.

Ajanta Pharma is a specialty pharmaceutical formulation company having branded generic business in India and emerging markets, generic business in US and institution business in Africa.

The company's net profit slumped 19.15% to Rs 122.25 crore in Q4 FY23 as compared with Rs 151.21 crore in Q4 FY22. Revenue from operations increased marginally to Rs 881.84 crore in Q4 FY23 as against Rs 870.29 crore recorded in same quarter last year.

Previous News
  Sensex tanks 909 pts; European mkt opens higher
 ( Market Commentary - Mid-Session 03-May-24   13:42 )
  Indices pare all early gains; metal shares rally for 2nd day
 ( Market Commentary - Mid-Session 03-May-24   10:36 )
  Volumes spurt at Ajanta Pharma Ltd counter
 ( Hot Pursuit - 03-May-24   14:30 )
  Ajanta Pharma
 ( Results - Analysis 06-May-23   21:31 )
  Ajanta Pharma consolidated net profit declines 20.08% in the September 2022 quarter
 ( Results - Announcements 03-Nov-22   16:33 )
  Ajanta Pharma
 ( Results - Analysis 03-Nov-22   20:33 )
  Ajanta Pharma fixes record date for bonus issue
 ( Market Beat - Reports 13-Jun-22   13:07 )
  Ajanta Pharma slides after Q4 PAT drops 19% YoY to Rs 122 cr
 ( Hot Pursuit - 08-May-23   11:45 )
  Ajanta Pharma
 ( Results - Analysis 10-May-22   16:35 )
  Volumes jump at Ajanta Pharma Ltd counter
 ( Hot Pursuit - 03-May-24   11:00 )
  Ajanta Pharma
 ( Results - Analysis 29-Jul-22   11:30 )
Other Stories
  Dredging Corp hits the roof on bagging Rs 156-cr order from Cochin Port Authority
  04-Jul-24   16:55
  Zydus Life jumps on USFDA nod for BP lowering drug
  04-Jul-24   16:28
  Bank of Maharashtra Q1 gross advances climb 19% YoY
  04-Jul-24   15:41
  ITD Cementation India Ltd leads losers in 'A' group
  04-Jul-24   15:00
  Equitas SFB Q1 gross advances grow 18% YoY
  04-Jul-24   14:53
  Tata Motors UK JLR registration rises 5% YoY in June
  04-Jul-24   14:50
  Remedium Lifecare Ltd leads losers in 'B' group
  04-Jul-24   14:45
  Volumes soar at Astrazeneca Pharma India Ltd counter
  04-Jul-24   14:30
  Sun Pharma gains on EMA nod for Nidlegy
  04-Jul-24   14:18
  GRM Overseas rises after securing basmati rice supply order from Bin Awadh Alnaqeeb Group
  04-Jul-24   14:01
Back Top